- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Singular Genomics Systems Inc.
Headquarters: San Diego, CA, United States
Website: https://singulargenomics.com/...
Year Founded: 2016
Status: Private
BioCentury | Feb 25, 2025
Deals
Counteroffer from Tang-backed Concentra could scuttle Acelyrin-Alumis: Deals Report
Plus Radiance gets ROR1 ADC from Cspc, Astrazeneca buys Fibrogen’s China subsidiary and more
BioCentury | Jul 25, 2024
Management Tracks
Mirati vet Charles Baum named CEO at Terremoto
Plus: Dave Daly at the helm at Exai Bio, and updates from Epitopea and FDA
BioCentury | Aug 2, 2022
Management Tracks
Astellas names Taniguchi CMO
Plus CSL hires Gisserot to lead Vifor and updates from Singular, Arbor and more
BioCentury | Mar 18, 2022
Management Tracks
Jha replaces Zients as COVID response coordinator
Plus games vet Jon David joins Akili, and updates from CorMedix and Seer
BioCentury | Feb 11, 2022
Deals
Feb. 10 Quick Takes: RA, Adjuvant ready Curevo to take on Shingrix with $60M A round
Seagen slides on guidance, and updates from Arkuda, Altesa, Aeglea, Congruence, 1859 and more
BioCentury | May 11, 2021
Finance
May 10 Quick Takes: Novavax sinks on vaccine submission delay; plus Alebund, Gennao, Therini, Singular Genomics and more
After closing down $15.50 (9%) to $160.50 Monday, Novavax Inc. (NASDAQ:NVAX) shed an additional 11% in after-hours trading following its announcement that the company will file for emergency
Items per page:
1 - 6 of 6